Corvus Pharmaceuticals Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$12.56

+0.01 (+0.08%)

As of Sep 20, 10:09 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 13 93%

Hold 1 7%

Sell 0 0%

Price Target

Analyst Price Target +261.5% upside

Low Target $29.32

Average Target $45.40

High Target $54.46

Current Price $12.56

Current
$12.56

Target
$45.40

$29.32 $45.40 avg $54.46

Scenario Analysis

Bear Case

$29.32

133.4%

Low target

Base Case

$45.40

+261.5%

Avg target

Bull Case

$54.46

+333.6%

High target

Risk/Reward

2.5x

Favorable

Price in Context

52-Week High

$26.95

-53.4% from high

52-Week Low

$5.72

+119.6% from low

Target vs 52W High

$45.40

+68.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-3.0%
AMGN Amgen Inc	Hold	43	47%	$190.87	-53.4%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.6%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-15.6%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.5%
MRNA Moderna Inc	Hold	30	37%	$149.45	-18.4%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-63.4%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-40.8%